BioNTech
BNTX
BNTX
292 hedge funds and large institutions have $4.95B invested in BioNTech in 2022 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 82 increasing their positions, 95 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
14% less repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 95
16% less capital invested
Capital invested by funds: $5.89B → $4.95B (-$936M)
42% less call options, than puts
Call options by funds: $394M | Put options by funds: $677M
Holders
292
Holding in Top 10
6
Calls
$394M
Puts
$677M
Top Buyers
| 1 | +$171M | |
| 2 | +$77.3M | |
| 3 | +$47.9M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$47.9M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$26.2M |
Top Sellers
| 1 | -$334M | |
| 2 | -$124M | |
| 3 | -$38.6M | |
| 4 |
Jennison Associates
New York
|
-$31.7M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$30.1M |